Investor Presentaiton slide image

Investor Presentaiton

Strong Financial Performance Revenue ($ millions) 23.7% CAGR 440 314 277 290 648 2018 2019 2020 2021 2022 //Andlauer HEALTHCARE GROUP EBITDA ($ millions)/ EBITDA Margin (%) 12 28.3% CAGR 119 174 79 71 27.1% 26.9% 64 25.1% 24.3% 23.2% 2018 2019 2020 2021 2022 1. EBITDA is defined as net income (loss) and comprehensive income (loss) for the period before: (i) income tax (recovery) expense; (ii) interest income; (iii) interest expense; and (iv) depreciation and amortization 2. Excluding the gain of $37.9 million on the step acquisition of 51% of Skelton USA Inc. in Q4 2021 12 12
View entire presentation